Murphy Melanie, Bennett Kathleen, Hughes Carmel M, Lavan Amanda, Cadogan Cathal A
School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Population Health Sciences Division, Royal College of Surgeons in Ireland, Dublin, Ireland.
Res Social Adm Pharm. 2020 Dec;16(12):1627-1631. doi: 10.1016/j.sapharm.2020.02.021. Epub 2020 Mar 5.
Older adults with cancer often require multiple medications including cancer-specific treatments and supportive care medications (e.g. analgesics), as well as medications for pre-existing medical conditions. Increasing numbers of medications pose risks of potentially inappropriate prescribing, drug-drug interactions and drug-disease interactions. The burden of treatment (i.e. the workload of healthcare and its impact on patient functioning and well-being) may also negatively affect the way patients take their medications. Non-adherence to medication in patients with cancer is associated with treatment failure and increased healthcare costs. Therefore, it is crucial that medicines are optimised for older adults with cancer to enhance appropriate prescribing, reduce the complexity of treatment regimens and minimise the risk of non-adherence.
To provide an overview of evaluations of interventions aimed at optimising medication prescribing and/or adherence in older adults with cancer.
A systematic scoping review will be undertaken. Four databases will be searched from inception: PubMed, EMBASE, CINAHL and PsycINFO. In order to meet inclusion criteria, studies must evaluate an intervention seeking to improve medication prescribing and/or adherence in older adults (aged ≥65 years) with an active cancer diagnosis using a comparative evaluation (e.g. inclusion of a control group). Two reviewers will independently screen titles and abstracts for inclusion and extract data relating to study population, intervention characteristics, outcome assessments and key findings. Extracted data will be collated using tables, figures and accompanying descriptive summaries. The review will be reported using the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines.
The scoping nature of this review will serve to provide an overview of the existing literature on interventions aimed at optimising medication prescribing and adherence in older adults with cancer. The review findings will help to identify research gaps and highlight areas to explore further in future research.
患有癌症的老年人通常需要多种药物治疗,包括针对癌症的特异性治疗药物和支持性护理药物(如镇痛药),以及用于治疗既往存在的疾病的药物。药物数量的增加带来了潜在不适当处方、药物相互作用和药物与疾病相互作用的风险。治疗负担(即医疗保健工作量及其对患者功能和福祉的影响)也可能对患者服药方式产生负面影响。癌症患者不遵医嘱服药与治疗失败及医疗费用增加有关。因此,优化针对患有癌症的老年人的药物治疗至关重要,以提高处方的合理性,降低治疗方案的复杂性,并将不遵医嘱服药的风险降至最低。
概述旨在优化患有癌症的老年人药物处方和/或服药依从性的干预措施的评估情况。
将进行一项系统的范围综述。从数据库创建之初开始检索四个数据库:PubMed、EMBASE、CINAHL和PsycINFO。为符合纳入标准,研究必须评估一项旨在改善患有活动性癌症诊断的老年人(年龄≥65岁)药物处方和/或服药依从性的干预措施,并采用比较评估(如纳入对照组)。两名评审员将独立筛选标题和摘要以确定是否纳入,并提取与研究人群、干预特征、结局评估和主要发现相关的数据。提取的数据将使用表格、图表及附带的描述性总结进行整理。本综述将按照系统评价和Meta分析扩展版的范围综述(PRISMA-ScR)指南进行报告。
本综述的范围性质将有助于概述现有关于旨在优化患有癌症的老年人药物处方和服药依从性的干预措施的文献。综述结果将有助于识别研究差距,并突出未来研究中需进一步探索的领域。